Loading
Senzime AB (publ.) Stock: price and insider trades · Sweden
2 insiders bought €82k of shares over the last 90 days, the latest by Sorin Brull, filed 28 Sept 2026.
Cluster: 2 buyers in 30 daysSenzime AB (publ.): what insiders have been doing
Senzime AB (publ.) is a Health Care company. Its directors and officers file their transactions with Finansinspektionen. From 24 October 2025 to 24 October 2026, the disclosure feed for Senzime AB (publ.) logged 13 filings by 3 insiders.
Both sides are active: 9 purchases worth €103k and 4 sales worth €20k, from 3 insiders and 1 insider respectively. Netting one side against the other leaves €83k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 3 board members. Biggest ticket of the year: €43k, bought by Adam Dahlberg and made public on 28 September 2026 (0.083% of market cap).
For context, the typical company on the same exchange (median of 1,028 companies) published 9 filings over the same period, against 13 filings here. Looking back to 2019, when coverage begins, insiders filed 49 purchases and 8 sales.
The latest purchase is recent: it was published 26 days ago, on 28 September 2026. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades.
Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Insider Decl.
62
Thresholds
n/a
Buy Volume
€3M
49 ops. · all time
Sell Volume
€626,034
8 ops. · all time
Who traded when
BuySaleLars Axelsson3 buys4 sales
Per Wold-Olsen6 buys
Sorin Brull5 buys
Adam Dahlberg1 buy
Fundamental score
Ranked 24,308 of 26,316 companies
18.9
score / 100
Value8
Quality30
FCF yld-29%
Earn yld-31%
EV/EBITDA·
ROE-35%
Gross mgn33%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
SEK 2.82
Analyst consensus
1 analysts0.00/5
SEK 10.50Target SEK 10.50(+272%)SEK 10.50
Income statement
RevenueSEK 104M
Gross profitSEK 34.7M33% margin
EBITDA-SEK 114.5M-110% margin
Net income-SEK 137.4M-109.3% margin
Valuation
P/Book1.7x
Beta0.43
Balance sheet & cash
Market capSEK 443.3M
Total debtSEK 14M
Free Cash Flow-SEK 127.2M
Debt / Equity8%
Profitability & ownership
ROE-35.4%
ROA-18.6%
% insiders42.4%
% institutions23.9%
Last declaration on 28 September 2026
Declarations62 total
30,000 shares@ SEK 3.14320.016% mcap21.0% of flowAktieISIN SE0002478776FI:csv-19a9defc9b6460a3eebd
Canonical exit: 20 Dec 2026 (T+90)
30,000 shares@ SEK 2.87090.015% mcap19.1% of flowAktieISIN SE0002478776FI:csv-84e564437dda698faf3b
Canonical exit: 24 Dec 2026 (T+90)
30,000 shares@ SEK 2.89830.015% mcap19.4% of flowAktieISIN SE0002478776FI:csv-cb6d1a88ad6789d26fd8
Canonical exit: 23 Dec 2026 (T+90)
25,000 shares@ SEK 3.55470.015% mcap19.8% of flowAktieISIN SE0002478776FI:csv-362d5abdac536eac2e71
Canonical exit: 16 Dec 2026 (T+90)
25,000 shares@ SEK 3.69930.016% mcap20.7% of flowAktieISIN SE0002478776FI:csv-2219ff3afbc6a0e97d6d
Canonical exit: 9 Dec 2026 (T+90)
178,388 shares@ SEK 2.7140.083% mcap100.0% of flowAktieISIN SE0002478776FI:csv-e52502c94adcd1417962
Canonical exit: 27 Dec 2026 (T+90)
15,000 shares@ SEK 5.0117.0% of flowAktieISIN SE0002478776FI:csv-1db0d206daf6209b9e09
15,000 shares@ SEK 5.110.013% mcap34.3% of flowAktieISIN SE0002478776FI:A003U533-1
Canonical exit: 9 Mar 2026 (T+90)
15,900 shares@ SEK 4.84517.3% of flowAktieISIN SE0002478776FI:csv-3c8825ba8bfc9554b996
15,900 shares@ SEK 4.950.014% mcap35.0% of flowAktieISIN SE0002478776FI:A003U245-1
Canonical exit: 26 Feb 2026 (T+90)
4,100 shares@ SEK 5.014.6% of flowAktieISIN SE0002478776FI:csv-c7a2cf30a71f67c5dd7f
9,500 shares@ SEK 4.9510.6% of flowAktieISIN SE0002478776FI:csv-8ad82c0a2e9c61881c50
13,600 shares@ SEK 5.070.012% mcap30.7% of flowAktieISIN SE0002478776FI:A003U066-1
Canonical exit: 19 Feb 2026 (T+90)
50,000 shares@ SEK 6.27860.054% mcap33.9% of flowAktieISIN SE0002478776FI:A003S554-1
Canonical exit: 22 Dec 2025 (T+90)
150,000 shares@ SEK 4.07050.11% mcap66.1% of flowAktieISIN SE0002478776FI:A003N503-1
Canonical exit: 21 Jul 2025 (T+90)
90,000 shares@ SEK 5.710817.5% of flowAktieISIN SE0002478776FI:csv-955d4a59f5a8908f8a7f
Canonical exit: 23 Feb 2025 (T+90)
100,000 shares@ SEK 6.143620.7% of flowAktieISIN SE0002478776FI:csv-f0864328f67ffd024ad9
Canonical exit: 10 Feb 2025 (T+90)
100,000 shares@ SEK 6.099520.6% of flowAktieISIN SE0002478776FI:csv-f518bb8d96513e5c25fd
Canonical exit: 11 Feb 2025 (T+90)
26,344 shares@ SEK 6.205.4% of flowAktieISIN SE0002478776FI:csv-9ad5c692f56e7ea7f002
Canonical exit: 4 Feb 2025 (T+90)
200,000 shares@ SEK 0.4523.0% of flowOptionISIN SE0002478776FI:csv-0d0d720018270ec77c2b
Canonical exit: 8 Aug 2024 (T+90)
100,000 shares@ SEK 0.4520.2% of flowOptionISIN SE0002478776FI:csv-16b1a4b10a9c89831365
500 shares@ SEK 3.001.4% of flowAktieISIN SE0002478776FI:csv-4673fb0c2aef8615337a
Canonical exit: 20 Sept 2023 (T+90)
3,300 shares@ SEK 3.009.4% of flowAktieISIN SE0002478776FI:csv-5749b3832787a27cd7f2
Canonical exit: 28 Sept 2023 (T+90)
2,435 shares@ SEK 4.069.4% of flowAktieISIN SE0002478776FI:csv-0a684a3b083c85290b3e
Canonical exit: 8 Oct 2023 (T+90)
2,000 shares@ SEK 5.4410.3% of flowAktieISIN SE0002478776FI:csv-d1cc254650530806862a
Canonical exit: 3 Dec 2023 (T+90)
25 of 62 declarations
About Senzime AB (publ.)
Senzime AB is a Swedish company focused on developing patient monitoring solutions for healthcare. It is listed on the XSTO market.
